Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab.

Autor: Shiga, Hisashi1 shiga@med.tohoku.ac.jp, Nagai, Hiroshi1, Shimoyama, Yusuke1, Naito, Takeo1, Moroi, Rintaro1, Kakuta, Yoichi1, Kinouchi, Yoshitaka2, Masamune, Atsushi1
Zdroj: Intestinal Research. Jul2024, Vol. 22 Issue 3, p378-386. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje